Alvotech (ALVO) Tax Provisions (2021 - 2026)
Alvotech's (ALVO) quarterly Tax Provisions came in at -$59000.0 in Q2 2026, down 100.26% on a YoY basis from $22.7 million in Q2 2025, and down 234.09% quarter-over-quarter from $44000.0 in Q1 2026.
Analysis
Alvotech (ALVO) Tax Provisions (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Tax Provisions for 6 consecutive years, with -$59000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Provisions fell 100.26% year-over-year to -$59000.0; the trailing twelve-month figure through Jun 2026 stood at $39.8 million (up 4.64% YoY), and the FY2025 full-year result was -$108.4 million, down 658.19% from the prior year.
- Tax Provisions slipped to -$59000.0 in Q2 2026 per ALVO's latest filing, from $44000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $99.3 million in Q1 2023 and bottomed at -$55.1 million in Q2 2022.
- Historically, Tax Provisions has averaged $16.2 million across 5 years, with a median of $16.7 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Tax Provisions jumped 6641.38% in 2022, then plunged 156.51% in 2024.
- Over 5 years, Tax Provisions stood at $17.1 million in 2022, then jumped by 88.85% to $32.2 million in 2023, then tumbled by 144.36% to -$14.3 million in 2024, then soared by 372.62% to $39.0 million in 2025, then plunged by 100.15% to -$59000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$59000.0, $44000.0, and $39.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 121.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 54.80 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 12.44 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 1.38 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 88.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -59,000.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 12.40 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 8.20 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 42,000.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -59,000.00 |
| Mar 31, 2026 | 44,000.00 |
| Dec 31, 2025 | 38.99 Mn |
| Sep 30, 2025 | 835,000.00 |
| Jun 30, 2025 | 22.73 Mn |
| Mar 31, 2025 | 16.26 Mn |
| Dec 31, 2024 | -14.30 Mn |
| Sep 30, 2024 | 13.36 Mn |
| Jun 30, 2024 | -11.57 Mn |
| Mar 31, 2024 | 6.44 Mn |
| Dec 31, 2023 | 32.24 Mn |
| Aug 31, 2023 | 49.85 Mn |
| Jun 30, 2023 | 20.47 Mn |
| Mar 20, 2023 | 99.32 Mn |
| Dec 31, 2022 | 17.07 Mn |
| Aug 31, 2022 | 17.07 Mn |
| Jun 30, 2022 | -55.14 Mn |
| Mar 20, 2022 | 38.07 Mn |
| Dec 31, 2021 | -261,000.00 |
| Sep 30, 2021 | 22.04 Mn |